Case Study: Treating KRAS-Mutant Adenocarcinoma - YouTube
Panelists discuss the second-line treatment of a 46 year-old woman with KRAS-positive nonsquamous non-small cell lung cancer following treatment with bevaciz Skip navigation Treating KRAS-Mutant Adenocarcinoma OncLiveTV. Subscribe Subscribed Unsubscribe 1,363 1K. K-Ras: The ... View Video
KRAS Testing Before Anti-EGFR Therapy - About.com Health
KRAS testing, which is a test to testing for what is known as the KRAS mutation before beginning anti-epidermal growth factor receptor (EGFR) Understanding Genetic Testing for Lung Cancer; Carcinoembryonic Antigen (CEA) Colorectal Cancer Drug Index; ... Read Article
Mothers Against Decapentaplegic Homolog 4 - Wikipedia, The ...
SMAD 4, also called SMAD family member n°4 or Mothers against decapentaplegic homolog 4, is a protein involved in cell signaling in mammals. The mutation can be inherited or acquired during an individual’s lifetime. If inherited, ... Read Article
Kanker Paru-paru - Wikipedia Bahasa Indonesia, Ensiklopedia Bebas
Mutasi pada proto-onkogen K-ras bertanggung jawab atas 10–30% adenokarsinoma paru. Reseptor faktor pertumbuhan epidermal (EGFR) mengatur proliferasi sel, apoptosis, angiogenesis, dan invasi tumor. Mutasi ... Read Article
Prognostic Role Of KRAS mutation In Non-small-cell lung ...
Interview with Dr Ken O'Byrne on the prognostic role of KRAS mutation in non-small-cell lung cancer: Interview with Dr Ken O'Byrne on the prognostic role of KRAS mutation in non-small-cell lung cancer: K-Ras: The Renegades of ... View Video
Dr. Gandara On Strategies For Overcoming KRAS Mutations In ...
David Gandara, MD, professor, Division of Hematology/Oncology, University of California Davis Comprehensive Cancer Center, discusses overcoming KRAS mutations in lung cancer. Gandara presented on this topic at the 15th Annual International Lung Cancer Congress®. For more resources ... View Video
No comments:
Post a Comment